Clinical Trial Update: Bone Marrow Stem Cell Infusion Following a Heart Attack [Phase 1]

View source ↗

Summary

Phase 1 trial update on autologous bone marrow stem cell infusion following an acute myocardial infarction; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Autologous bone marrow stem cell infusion (bone marrow stem cell infusion)

Snippet

Sponsor: Minneapolis Heart Institute Foundation | Conditions: Acute Myocardial Infarction | Phase 1 | Status: COMPLETED